OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALLKathryn Evans, Richard B. Lock, Tara Pritchard et al.|Clinical Cancer Research|2019Cited by 53
Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expressionBarbara J. McClure, Deborah L. White, Jiyuan An et al.|British Journal of Cancer|2018Cited by 44
A single nucleotide polymorphism genotyping platform for the authentication of patient derived xenograftsJad El‐Hoss, Richard B. Lock|Oncotarget|2016Cited by 29